| Entry |
|
| Name |
TRK fusion kinase to RAS-ERK signaling pathway
|
| Definition |
TRK* -> RAS -> RAF -> MEK -> ERK |
| Expanded |
4914v1 -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
|
| Gene |
| 4914 | NTRK1; neurotrophic receptor tyrosine kinase 1 |
| 3265 | HRAS; HRas proto-oncogene, GTPase |
| 3845 | KRAS; KRAS proto-oncogene, GTPase |
| 4893 | NRAS; NRAS proto-oncogene, GTPase |
| 369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
| 673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
| 5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
| 5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
| 5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
| 5594 | MAPK1; mitogen-activated protein kinase 1 |
| 5595 | MAPK3; mitogen-activated protein kinase 3 |
|
| Variant |
|
| Reference |
|
| Authors |
Kondo T, Ezzat S, Asa SL. |
| Title |
Pathogenetic mechanisms in thyroid follicular-cell neoplasia. |
| Journal |
|
| Reference |
|
| Authors |
Gimm O. |
| Title |
Thyroid cancer. |
| Journal |
|
| LinkDB |
|